-0.64   (-6.10%)
Pre-market: .00 -9.85 (-100.00%)
Volume (24h) Market Cap. Day Range 52w Range
7.37M 1.65B 9.72 - 10.59 2.10 - 33.79
Oct-29-20 02:41PM Looking Into Inovio Pharmaceuticals's Return On Capital EmployedBenzinga
Oct-28-20 03:58PM Why Coronavirus Vaccine Stocks Moderna, Novavax, and Inovio Are Sinking TodayMotley Fool
Oct-27-20 10:57PM Jim Cramer Talks AMD, Inovio And Honda MotorsBenzinga
Oct-26-20 12:00PM INOVIO to Report Third Quarter 2020 Financial Results on November 9, 2020PR Newswire
11:28AM Why a Student of Disruptive Innovation Is Betting on Tesla, Telehealth, and
Oct-24-20 10:30AM 2 Coronavirus Stocks to Avoid This MonthMotley Fool
Oct-23-20 11:45AM Could the FDA Be Ready to Crash Inovio’s Hopes and Dreams?InvestorPlace
11:00AM A Student of Disruptive Innovation Bets on Tesla, Telehealth, and
Oct-18-20 01:04PM Better Coronavirus Stock: Inovio Pharmaceuticals or VBI Vaccines?Motley Fool
Oct-17-20 11:40AM What You Need to Know at This Stage of the Coronavirus Vaccine RaceMotley Fool
Oct-15-20 03:31PM Big Pharma's Vaccine Race – A Chance For RedemptionBenzinga
Oct-12-20 10:42AM Why Is Everyone Talking About Inovio Stock?Motley Fool
Oct-10-20 11:00AM Could Inovio Pharmaceuticals Be a Millionaire-Maker Stock?Motley Fool
09:51AM 3 Top Robinhood Stocks to Avoid Like the Plague in OctoberMotley Fool
Oct-07-20 07:36PM Inovio: COVID-19 Vaccine Trial Delay Is Disappointing, But Not a Deal Breaker, Says AnalystTipRanks
11:15AM Should Inovio Be On Your Buy List As It Tackles A Coronavirus Vaccine?Investor's Business Daily
Oct-06-20 10:12AM Is Inovio a Bad-News Buy?Motley Fool
12:41AM Inovio Pharmaceuticals: The Questions Keep Piling UpTipRanks
Oct-05-20 10:06AM Millennial Investors: Buy This, Not ThatMotley Fool
Oct-04-20 12:07PM The 3 Most Expensive Stocks to Avoid During a Market CrashMotley Fool
Oct-03-20 12:20PM Should Investors Give Up on Inovio Pharma Stock?Motley Fool
Oct-02-20 05:45PM Don’t Count Out Inovio Pharmaceuticals Stock Just YetInvestorPlace
12:10PM This Latest FDA Hold Is a Crushing Blow for Reeling Inovio StockInvestorPlace
Oct-02-20 12:09PM If You’re Not a Speculator, You Should Avoid iBioInvestorPlace
Sep-30-20 10:01AM Some Analysts Just Cut Their Inovio Pharmaceuticals, Inc. (NASDAQ:INO) EstimatesSimply Wall St.
Sep-29-20 09:35PM Antibody Cocktail Shows Promise; NYC Positivity Up: Virus UpdateBloomberg
08:07PM Don’t Go Bargain Hunting on Inovio (INO) Stock Quite Yet, Says 5-Star AnalystTipRanks
Sep-29-20 08:05PM U.S. Cases Rise 0.6%; Global Deaths Top 1 Million: Virus UpdateBloomberg
07:04PM Global Deaths Top 1 Million; North Dakota Cases: Virus UpdateBloomberg
Sep-29-20 05:55PM Global Deaths Top 1 Million; N.Y.C. Positive Rate: Virus UpdateBloomberg
04:26PM Global Deaths Top 1 Million; N.Y.C. Positive Rate: Virus UpdateBloomberg
Sep-29-20 03:17PM Global Deaths Top 1 Million; U.S. Hospitalizations: Virus UpdateBloomberg
02:48PM Global Deaths Top 1 Million; U.S. Hospitalizations: Virus UpdateBloomberg
Sep-29-20 01:32PM Global Deaths Top 1 Million; Boris Johnson’s Gaffe: Virus UpdateBloomberg
11:20AM Deaths Top 1 Million; Germany May Limit Parties: Virus UpdateBloomberg
Sep-29-20 08:48AM Deaths Top 1 Million; India Scrambles for Oxygen: Virus UpdateBloomberg
07:43AM Inovio Plunges after COVID-19 Vaccine SetbackFX Empire
Sep-29-20 06:54AM Global Deaths Top 1 Million; India Lacks Oxygen: Virus UpdateBloomberg
06:25AM Inovio Dives 28% After FDA Halts COVID-19 Vaccine TrialSmarterAnalyst
Sep-29-20 06:12AM Global Deaths Reach 1 Million; India Sees Slowdown: Virus UpdateBloomberg
04:48AM Global Deaths Reach 1 Million; ‘New Poor’ Emerge: Virus UpdateBloomberg
Sep-29-20 03:10AM Global Deaths Reach 1 Million; ‘New Poor’ Emerge : Virus UpdateBloomberg
12:59AM Coronavirus update: World tops 1M deaths; Inovio delays late-stage trial as vaccine race quickensYahoo Finance
Sep-28-20 08:23PM Inovio Forced To Delay Planned Testing Of Covid-19 Vaccine; Stock PlummetsInvestor's Business Daily
08:03PM Nasdaq Shrugs Off Uncertainty as Piedmont Lithium Soars on Tesla Deal; Inovio Plunges on Clinical HaltMotley Fool
Sep-28-20 07:46PM Inovio Stock Tumbles After Covid-19 Vaccine Trial Is
07:13PM Inovio Coronavirus Vaccine Candidate Trial Halted Due to FDA InquiryMotley Fool
Sep-28-20 06:44PM Inovio Stock Tumbles After Covid-19 Vaccine Trial Is
05:31PM Coronavirus update: World nears 1M deaths; Inovio delays late-stage trial as vaccine race quickensYahoo Finance
Sep-28-20 04:15PM Dow Jones Vaults 500 Points To Retake Key Support In Broad Stock Market RallyInvestor's Business Daily
Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines to prevent and treat cancers and infectious diseases. Its SynCon immunotherapy design has the ability to break the immune system's tolerance of cancerous cells, as well as is intended to facilitate cross-strain protection against known, as well as new unmatched strains of pathogens, such as influenza. The company is involved in conducting and planning clinical programs of its proprietary SynCon immunotherapies for HPV-caused pre-cancers and cancers; prostate, breast, lung, and pancreatic cancers; hepatitis C virus; hepatitis B virus; human immunodeficiency virus; Ebola virus; middle east respiratory syndrome; and Zika virus. Its partners and collaborators include MedImmune, LLC, The Wistar Institute, University of Pennsylvania, GeneOne Life Science Inc., Regeneron Pharmaceuticals, Inc., Genentech, Inc., Plumbline Life Sciences, Inc., the Parker Institute for Cancer Immunotherapy, Drexel University, National Microbiology Laboratory of the Public Health Agency of Canada, National Institute of Allergy and Infectious Diseases, United States Military HIV Research Program, U.S. Army Medical Research Institute of Infectious Diseases, National Institutes of Health, HIV Vaccines Trial Network, Defense Advanced Research Projects Agency, and Coalition for Epidemic Preparedness Innovations. Inovio Pharmaceuticals, Inc. was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.
Cap:    |  Volume (24h):